Abbott Laboratories (ABT) Share-based Compensation (2009 - 2026)

Abbott Laboratories' Share-based Compensation history runs 18 years deep, the most recent figure standing at $317.0 million for Q1 2026.

• In Q1 2026, Share-based Compensation rose 9.69% year-over-year to $317.0 million; the TTM figure through Mar 2026 stood at $692.0 million (up 5.17% YoY), while the FY2025 annual figure was $664.0 million, down 1.34% from the prior year.
• Share-based Compensation came in at $317.0 million for Q1 2026 at Abbott Laboratories, up from $113.0 million in the prior quarter.
• In the past five years, Share-based Compensation ranged from a high of $317.0 million in Q1 2026 to a low of $111.0 million in Q4 2024.
• A 5-year average of $175.5 million and a median of $132.0 million in 2023 frame the typical range for Share-based Compensation.
• Across the five-year window, Share-based Compensation fell 7.87% in 2023 and rose 9.69% in 2026, its largest moves.
• Abbott Laboratories' Share-based Compensation stood at $115.0 million in 2022, then dropped by 0.87% to $114.0 million in 2023, then declined by 2.63% to $111.0 million in 2024, then grew by 1.8% to $113.0 million in 2025, then soared by 180.53% to $317.0 million in 2026.
• According to Business Quant data, Share-based Compensation over the past three periods registered $317.0 million, $113.0 million, and $120.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison